SCHEDULE-14A

Company

Edesa Biotech, Inc.

Filed

April 1, 2022

Period of Report

May 18, 2022

Accession Number

0001654954-22-004476

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →